169 related articles for article (PubMed ID: 8810317)
1. Regulation of mutant p53 temperature-sensitive DNA binding.
Friedlander P; Legros Y; Soussi T; Prives C
J Biol Chem; 1996 Oct; 271(41):25468-78. PubMed ID: 8810317
[TBL] [Abstract][Full Text] [Related]
2. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
Hansen S; Hupp TR; Lane DP
J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
[TBL] [Abstract][Full Text] [Related]
3. Novel DNA binding of p53 mutants and their role in transcriptional activation.
Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
[TBL] [Abstract][Full Text] [Related]
4. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
Lin SR; Yang YC; Jung JH; Tsai JH
DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
[TBL] [Abstract][Full Text] [Related]
5. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.
Nie Y; Li HH; Bula CM; Liu X
Mol Cell Biol; 2000 Feb; 20(3):741-8. PubMed ID: 10629029
[TBL] [Abstract][Full Text] [Related]
7. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
8. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
10. p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner.
Miller SD; Farmer G; Prives C
Mol Cell Biol; 1995 Dec; 15(12):6554-60. PubMed ID: 8524220
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of DNA binding sites by mutant p53 proteins.
Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic forms of p53 inhibit p53-regulated gene expression.
Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B
Science; 1992 May; 256(5058):827-30. PubMed ID: 1589764
[TBL] [Abstract][Full Text] [Related]
13. The p53 protein is an unusually shaped tetramer that binds directly to DNA.
Friedman PN; Chen X; Bargonetti J; Prives C
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3319-23. PubMed ID: 8475074
[TBL] [Abstract][Full Text] [Related]
14. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
15. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.
Abarzúa P; LoSardo JE; Gubler ML; Neri A
Cancer Res; 1995 Aug; 55(16):3490-4. PubMed ID: 7627952
[TBL] [Abstract][Full Text] [Related]
16. Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53.
Fojta M; Pivonkova H; Brazdova M; Kovarova L; Palecek E; Pospisilova S; Vojtesek B; Kasparkova J; Brabec V
Biochem Pharmacol; 2003 Apr; 65(8):1305-16. PubMed ID: 12694871
[TBL] [Abstract][Full Text] [Related]
17. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
[TBL] [Abstract][Full Text] [Related]
18. A temperature-sensitive mutant of human p53.
Zhang W; Guo XY; Hu GY; Liu WB; Shay JW; Deisseroth AB
EMBO J; 1994 Jun; 13(11):2535-44. PubMed ID: 8013454
[TBL] [Abstract][Full Text] [Related]
19. Binding of the growth suppressor p53 protein to the cell cycle regulator phosphatase cdc25C.
Rief N; Herges H; Prowald A; Götz C; Montenarh M
Int J Oncol; 2000 Jul; 17(1):189-95. PubMed ID: 10853038
[TBL] [Abstract][Full Text] [Related]
20. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.
Jayaraman J; Prives C
Cell; 1995 Jun; 81(7):1021-9. PubMed ID: 7600571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
